pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
766
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
HLTX-001
Neuroblastoma
Hula Therapeutics Inc
0
catalysts
Phase 1
HM-16390
Colorectal Cancer
Hanmi Pharmaceuticals Co Ltd
0
catalysts
Phase 1
HM-17321
Obesity
Hanmi Pharmaceuticals Co Ltd
0
catalysts
Phase 1
HMS-1005
← prev
page 11 of 26
next →
131
Pain
89
Neurology
1
Type 2 Diabetes
Hua Medicine Shanghai Ltd
0
catalysts
Phase 1
HNC-042
Unspecified Influenza Virus Infections
Guangzhou Henovcom Bioscience Co Ltd
0
catalysts
Phase 1
HNC-1058
Idiopathic Pulmonary Fibrosis
Guangzhou Henovcom Bioscience Co Ltd
0
catalysts
Phase 1
HNC-364
Parkinson's Disease
Guangzhou Henovcom Bioscience Co Ltd
0
catalysts
Phase 1
HNSA-5487
Guillain-Barre Syndrome
Hansa Biopharma AB
0
catalysts
Phase 1
HNSCC
Hypopharyngeal Cancer
Metaclipse Therapeutics Corp
0
catalysts
Phase 1
HWK-007
Endometrial Cancer
$WHWK
Whitehawk Therapeutics, Inc.
0
catalysts
Phase 1
HWK-016
Endometrial Cancer
$WHWK
Whitehawk Therapeutics, Inc.
0
catalysts
Phase 1
HY-083
Non Allergic Rhinitis
Hyloris Pharmaceuticals SA
0
catalysts
Phase 1
HY-1003
Emphysema
Wuhan Healthgen Biotechnology Corp
0
catalysts
Phase 1
HbF Activating CELMoD
Sickle Cell Disease
Bristol-Myers Squibb Co
0
catalysts
Phase 1
Hemay-181
Colon Cancer
Ganzhou Hemei Pharmaceutical Co Ltd
0
catalysts
Phase 1
IA-14069
Rheumatoid Arthritis
iLab Co Ltd
0
catalysts
Phase 1
IAM-1363
Bladder Cancer
Iambic Therapeutics Inc
0
catalysts
Phase 1
IBI-3020
Colon Cancer
Innovent Biologics Inc
0
catalysts
Phase 1
IBI-3032
Obesity
Innovent Biologics Inc
0
catalysts
Phase 1
IBRX-042
Head And Neck Cancer
$IBRX
ImmunityBio, Inc.
0
catalysts
Phase 1
ICG-122
T-Cell Leukemia
iCell Gene Therapeutics LLC
0
catalysts
Phase 1
ICG-124
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
iCell Gene Therapeutics LLC
0
catalysts
Phase 1
IDE-034
Castration-Resistant Prostate Cancer (CRPC)
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 1
IDE-574
Breast Cancer
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 1
IDE-892
Esophageal Squamous Cell Carcinoma (ESCC)
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 1
IDOV-Immune
Solid Tumor
Viromissile Inc
0
catalysts
Phase 1
IKS-03
B-Cell Non-Hodgkin Lymphoma
Iksuda Therapeutics Ltd
0
catalysts
Phase 1
IM-1021
Diffuse Large B-Cell Lymphoma
$IMNM
Immunome Inc.
0
catalysts
Phase 1
IM-3050
Solid Tumor
$IMNM
Immunome Inc.
0
catalysts
Phase 1
IMC-002
Solid Tumor
ImmuneOncia Therapeutics Inc
0
catalysts
